Pioglitazone Tablet
Product Images NDC 57237-219

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 57237-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

A line graph showing the mean change from baseline for HbA1c over 26 weeks in a placebo-controlled dose-ranging study of Pioglitazone tablets at 15 mg, 30 mg, and 45 mg doses. The x-axis represents weeks (0 to 26), and the y-axis represents the mean change in HbA1c, ranging from -2.0 to 1.0. The graph includes lines for placebo and the three dosage strengths, illustrating observed values over time.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))

Label for Pioglitazone Tablets, USP 15 mg, oral tablets by Rising Pharma Holdings, Inc. The label states a package size of 30 tablets, includes storage instructions at 20° to 25°C, and notes the product is Rx only. It is distributed by Rising Health, LLC and made in India, with an NDC of 57237-219-30.*

FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))

Pioglitazone Tablets, USP 30 mg oral tablets packaging label from Rising Pharma Holdings, Inc. The label indicates a 30-tablet count and includes NDC 57237-220-30. It provides storage instructions, distributor information (Rising Health, LLC, Saddle Brook, NJ), and states the product is made in India. The label is marked Rx only.*

FDA Label Image

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))

Label for Pioglitazone Tablets USP 45 mg oral tablets, containing 30 tablets per bottle. The label is from Rising Pharma Holdings, Inc., distributed by Rising Health, LLC, and includes storage instructions and a barcode. The label notes that each tablet contains pioglitazone hydrochloride equivalent to 45 mg pioglitazone, and it is for prescription use only.*

FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical structure of Pioglitazone hydrochloride depicted as a molecular diagram showing its atoms and bonds, including its thiazolidinedione ring and aromatic groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.